Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-26-035646
Filing Date
2026-07-31
Accepted
2026-07-31 16:25:30
Documents
1
Period of Report
2026-07-27

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1725
  Complete submission text file 0001493152-26-035646.txt   3202
Mailing Address 5 BASEL STREET, PO BOX 3190 PETACH TIKVA L3 4951033
Business Address
O'Grady Brendan P. (Reporting) CIK: 0001726533 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42796 | Film No.: 261228862

Mailing Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003
Business Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003 972 54-255-3956
Nasus Pharma Ltd (Issuer) CIK: 0002029039 (see all company filings)

EIN.: 516022712 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)